Jul 2026· Journal of Bone and Mineral Research· 0 citations
Medicine
TL;DR
Overall, the data reveal the profound, yet variable, phenotype in ADO and indicate that HR-pQCT measures correlate with disease severity and represent potential surrogate endpoints for future therapeutic trials.
Abstract
Autosomal dominant osteopetrosis (ADO) is a rare bone disorder caused by impaired osteoclastic resorption. Despite high bone mass, ADO is paradoxically associated with increased fracture risk. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides unique, low-radiation assessments of bone, but prior studies in ADO are limited to small case series. Using baseline cross-sectional data from an ongoing natural history study, we characterized HR-pQCT phenotypes in adults with ADO and explored associations with self-reported fracture history and bone turnover markers. HR-pQCT outcomes at the distal ends and shafts of the radius and tibia in 48 adults with ADO were compared to 144 matched controls (1:3 ratio). In addition, z-scores for outcomes in ADO were calculated using established reference data. At trabecular-rich distal sites, ADO demonstrated markedly elevated total volumetric bone mineral density (vBMD), trabecular vBMD, trabecular bone volume fraction, trabecular thickness, and estimated failure load (all p<0.001), with values often approaching or exceeding twice those in controls. At cortical-rich shaft sites, total vBMD, bone area, bone area fraction, and cortical thickness were greater in ADO (all p<0.05). However, there was considerable interindividual variability, with some individuals having normal z-scores while others exhibited z-scores exceeding +20. The phenotype reflected increased bone mass rather than mineralization—cortical vBMD was normal and tissue mineral density was normal-to-lower in ADO. Outcomes at both distal and shaft sites were strongly correlated with lifetime fracture number (Spearman ρ=0.64–0.75, p<0.001), indicating ADO individuals with the “strongest” bones (via microfinite element modeling) reported most fractures. The outcomes were correlated inversely with serum C-telopeptide and positively with serum tartrate resistant acid phosphatase 5b, consistent with ADO being rich with dysfunctional osteoclasts. Overall, the data reveal the profound, yet variable, phenotype in ADO and indicate that HR-pQCT measures correlate with disease severity and represent potential surrogate endpoints for future therapeutic trials.
The trabecular bone score (TBS) provides complementary, indirect information on trabecular microarchitecture that may be independently impaired in SSc, and SSc patients exhibit significantly impaired bone microarchitecture compared with matched controls.
Nipaporn Intarasattakul, C. Pongchaiyakul, C. Foocharoen et al.· Journal of clinical densitom...· 0 citations
Bone microarchitecture deteriorates over time in adults with OI and more after menopause, however, longitudinal changes do not predict incident fractures, highlighting the complex determinants of fracture risk in OI.
Camille Blandin, A. Ostertag, Corinne Collet et al.· Bone· 0 citations
Assessment of bone mineral density (BMD), trabecular bone score (TBS), and muscle mass in adults with PIDs found reduced BMD and impaired TBS represented distinct, partially overlapping findings.
A. Nowakowska-Płaza, J. Wroński, A. Zegadło et al.· Frontiers in Endocrinology· 0 citations
The study indicates that lower BHI SDS values are associated with increased fracture risk in children with classical OI and indicates that BHI may represent a clinically useful complementary tool for fracture risk stratification in young children with OI, particularly where DXA is unavailable or technically limited, in...
Ruggero Lanzafame, Alistair D. Calder, B. Crowe et al.· Journal of Clinical Endocrin...· 0 citations
Radiofrequency Echographic Multi Spectrometry (REMS) is an innovative ultrasound-based technique that enables non-invasive assessment of BMD and bone microarchitecture without ionizing radiation, and may be particularly valuable in patients with chronic kidney disease, including those with vascular calcifications.
Elvira Punturieri, R. Tripepi, Anna Mudoni et al.· Giornale di Clinica Nefrolog...· 0 citations
In this study cohort, CKD patients with fractures exhibited a high-turnover bone phenotype with increased osteoid volume and altered bone histology, suggesting biochemical markers may serve as cost-effective adjuncts for fracture risk stratification, particularly where advanced diagnostics are limited.
Sushil Sharma, P. Sujir, Pranav Rajasekharan et al.· SAGE Open Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.